Prosthetic cardiac valve |
Previous infective endocarditis |
Congenital heart disease (CHD)* |
Unrepaired cyanotic CHD, including palliative shunts and conduits |
Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure† |
Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibits endothelialisation) |
Cardiac transplant recipients who develop cardiac valvulopathy |
*Except for the conditions listed above, antibiotic prophylaxis is no longer recommended for any other form of CHD.
†Prophylaxis is recommended because endothelialisation of prosthetic material occurs within 6 months after the procedure.